Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · March 06, 2015

NPM1-Positive/FLT3-ITD–Negative Genotype Favorable in AML Patients 55–65 Years Old

Journal of Clinical Oncology

 

Additional Info

Journal of Clinical Oncology
Prognostic Significance of NPM1 Mutations in the Absence of FLT3-Internal Tandem Duplication in Older Patients With Acute Myeloid Leukemia: A SWOG and UK National Cancer Research Institute/Medical Research Council Report
J. Clin. Oncol 2015 Feb 23;[EPub Ahead of Print], F Ostronoff, M Othus, M Lazenby, E Estey, FR Appelbaum, A Evans, J Godwin, A Gilkes, KJ Kopecky, A Burnett, AF List, M Fang, VG Oehler, SH Petersdorf, EL Pogosova-Agadjanyan, JP Radich, CL Willman, S Meshinchi, DL Stirewalt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading